← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2024Last known activity
Jan 31, 2024
Timeline
2000s
- Apr 15, 2008
sumatriptan— NDA Secondary Org
2010s
- Mar 17, 2010
doxepin— Marketing Organization
- May 1, 2019
Currax Pharmaceuticals— Founded
- Sep 27, 2019
Nalpropion— Acquired
Drugs by trial phase (2 distinct, 1 trials)
Phase 4 (2 own, 0 via acquisition)
Marketed drugs (6)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (1)
- NCT06098079Lead sponsorPhase 4Jan 31, 2024
Details
- Founded
- Morristown, NJ, US May 1, 2019
- Last known activity
- Jan 31, 2024